NI-22 NON-ENHANCING TUMOR RESPONSE USING QUANTITATIVE T2 MAPS PREDICTS SURVIVAL IN GLIOBLASTOMA TREATED WITH BEVACIZUMAB

BACKGROUND: Malignant gliomas are known to contain proportions of both neovascularized and infiltrative, non-enhancing tumor (NET). Additionally, a substantial proportion of treated tumors can have NET progression prior to contrast enhancement. There remains significant need for objective evaluation...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ellingson, Benjamin, Pope, Whitney, Nghiemphu, Phioanh, Lai, Albert, Cloughesy, Timothy
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2014
Onderwerpen:
Abstracts
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218347/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou264.21
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items